CNR1 Polyclonal Antibody, APC-Cy5.5 Conjugated
Product Specifications
Background
Involved in cannabinoid-induced CNS effects. Acts by inhibiting adenylate cyclase. Could be a receptor for anandamide. Inhibits L-type Ca (2+) channel current. Isoform 2 and isoform 3 have altered ligand binding.
Synonyms
CB1; CNR; CB-R; CB1A; CB1R; CANN6; CB1K5; Cannabinoid receptor 1; CNR1
Gene ID
1268
Swiss Prot
P21554
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human, Rat
Immunogen
401-472/472
Target
CNR1
Clonality
Polyclonal
Isotype
IgG
Conjugation
APC-Cy5.5
Source
KLH conjugated synthetic peptide derived from human CNR-1
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
650nm/694nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
1268
Predicted Cross Reactivity
Mouse, Dog, Cow, Pig, Horse, Rabbit, GuineaPig
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6390304-01 0.1 mL
PPFIBP2 (Liprin-beta-2, Protein Tyrosine Phosphatase Receptor Type F Polypeptide-interacting Protein-binding Protein 2, PTPRF-interacting Protein-binding Protein 2, DKFZp781K06126, MGC42541) (MaxLight 650)
Ask
View Details MBS6390304-02 5x 0.1 mL
PPFIBP2 (Liprin-beta-2, Protein Tyrosine Phosphatase Receptor Type F Polypeptide-interacting Protein-binding Protein 2, PTPRF-interacting Protein-binding Protein 2, DKFZp781K06126, MGC42541) (MaxLight 650)
Ask
View Details 
